|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a study concerning maximum lifetime benefit limits |
|
|
under health benefit plan coverage applicable to |
|
|
hemophilia-related services, supplies, pharmaceuticals, and |
|
|
biologics. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. DEFINITION. In this Act, "department" means the |
|
|
Texas Department of Insurance. |
|
|
SECTION 2. STUDY. (a) The department shall conduct a study |
|
|
of the maximum lifetime benefit limits under health benefit plan |
|
|
coverage as those limits are applied to hemophilia-related |
|
|
services, supplies, pharmaceuticals, and biologics. |
|
|
(b) In conducting the study, the department shall consult |
|
|
health benefit plan issuers, physicians, organizations |
|
|
representing the interests of individuals with hemophilia, and the |
|
|
office of public insurance counsel. |
|
|
(c) The study must consider the manner in which |
|
|
hemophilia-related services, supplies, pharmaceuticals, and |
|
|
biologics are provided by the Texas Health Insurance Risk Pool. |
|
|
SECTION 3. REPORT. Not later than September 1, 2008, the |
|
|
department shall report the results of the study conducted under |
|
|
this Act to the governor, the lieutenant governor, and the speaker |
|
|
of the house of representatives. The report must include: |
|
|
(1) the estimated cost for an enrollee of providing |
|
|
coverage for hemophilia-related services, supplies, |
|
|
pharmaceuticals, and biologics without a maximum lifetime benefit |
|
|
limit or with an increased maximum lifetime benefit limit; |
|
|
(2) a review of the benefits to enrollees of providing |
|
|
coverage for hemophilia-related services, supplies, |
|
|
pharmaceuticals, and biologics without a maximum lifetime benefit |
|
|
limit or with an increased maximum lifetime benefit limit; and |
|
|
(3) the recommendation of the commissioner of |
|
|
insurance, if any, for legislation concerning the maximum lifetime |
|
|
benefit limits under health benefit plan coverage as those limits |
|
|
are applied to hemophilia-related services, supplies, |
|
|
pharmaceuticals, and biologics. |
|
|
SECTION 4. EXPIRATION. This Act expires June 1, 2009. |
|
|
SECTION 5. EFFECTIVE DATE. This Act takes effect September |
|
|
1, 2007. |